Obesity, hypertension and diabetes are known risk
factors for heart failure, a chronic condition in which the heart can not pump enough blood to meet the body's needs.
Because of the aging population, the estimated prevalence and cost of
care for heart failure is expected to increase dramatically.
In addition to publishing over 200 scholarly articles, her research has led to new diagnostic
tests for heart failure and the genetics of cardiac birth defects.
Future studies aimed at whether this is a productive versus a faulty adaptive fuel shift could lead to new therapeutic
avenues for heart failure.
Although there is no
cure for heart failure, medications can treat various symptoms and contributing factors, so it's important to see a doctor, she said.
Some of them now find their health or lives at risk because they can't access basic health care such as
medication for heart failure, and insulin for diabetes.
A weakening of the heart muscle that prevents the organ's efficient operation, heart failure affects around 5.7 million adults in the U.S., and about 40 percent of those
hospitalized for heart failure exacerbation are obese, the authors note.
Although supervised aerobic physical activity is a proven
therapy for heart failure patients, lack of social support and practical barriers such as lack of transportation, keep many patients from benefitting from cardiac rehab programs, according to new research in Circulation: Heart Failure, an American Heart Association journal.
Dr Kristensen continued: «We found an increased risk of hospitalization
for heart failure in IBD patients of all ages, not just older patients.
Analysis of the results for the entire group of 1,664 patients found a significant and rapid reduction in the incidence of emergency treatment or hospitalization
for heart failure exacerbation in the two years after surgery.
Mesoblast limited (ADR)(NASDAQ: MESO), a developer of adult stem cell - based products, has struggled to meet key clinical timelines and lost a key partnership with Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE: TEVA)
for a heart failure program, according to Credit Suisse.
According to the researchers, patients randomized to spironolactone were less likely to be hospitalized
for heart failure compared to those on placebo.
In March last year, the FDA approved Perin's request to conduct the country's first advanced, randomized, double - blind clinical trial of stem
cells for heart failure.
The scientific evidence
for the heart failure recommendation comes from a large, randomized, clinical trial that showed a low dose of omega - 3 fish oil supplements reduced death and hospitalization by 9 percent in patients with heart failure, which led the authors to determine that healthcare providers could consider omega - 3 fish oil supplements reasonable for these patients.
SAN FRANCISCO, CA — A new biopharmaceutical company, Tenaya Therapeutics Inc., will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug
discovery for heart failure.
TUESDAY, April 18, 2017 (HealthDay News)-- Implanted pumps may be more than a «bridge» to a heart transplant — they might also restore healthy heart
function for some heart failure patients, a new British study suggests.
We believe that the results of this trial will be most important when it comes to defining the role of iron repletion
for heart failure iron deficient patients in the next ESC Heart Failure guidelines in 2016.»
Answer: Long term steroids, just in general, aren't the
greatest for heart failure patients, but they can definitely take a little dexamethasone if it eases some other ailment that might be harder on their heart.
Current treatments
for heart failure come in the form of medications like ACE inhibitors, beta blockers, and diuretics to reduce fluid buildup.
Vetmedica, Home Care of the Heart Failure Patient by O.L. Nelson DVM MS Diplomate ACVIM Washington State University Medications Commonly Used
for Heart Failure by O.L. Nelson DVM MS Diplomate ACVIM Washington State University
Patients with a poor diuretic response had less dyspnoea relief (p = 0.0001) and a higher risk of cardiovascular death or
rehospitalisation for heart failure or renal failure through day 60 (p < 0.004).
«While these patients also suffer heart attacks and strokes, hospitalizations
for heart failure represent their predominant problem, which is also a major burden to society,» said Eldrin Lewis, MD, advanced heart failure specialist, BWH Division of Cardiovascular Medicine, Department of Medicine, who chaired the TOPCAT Clinical Endpoints Committee.
Cardiac function
assessment for heart failure, coronary angiography for ischaemic heart disease and Holter ECG monitoring for lethal arrhythmias can identify the type of myocardial injury and help physicians select a prophylactic therapeutic strategy against sudden cardiac death in hemodialysis patients.»
The current study used prospectively collected electronic health records to investigate the contemporary incidence and risk factors
for heart failure after a first myocardial infarction.
People with type 2 diabetes admitted to the hospital
for heart failure faced a 24 to 28 percent chance of death during the remainder of the trial, on aloglipin or placebo respectively.
Most important, the study concluded, individuals with a psychiatric concern probably accounted for an even larger proportion of
admissions for heart failure, AMI or pneumonia, but because mental health conditions are often not diagnosed, these illnesses weren't captured in medical records.
Researchers used national data from the American Heart Association's Get With The Guidelines - Heart Failure program and the U.S. Centers for Medicare and Medicaid Services and included 39,982 patients from 254 hospitals
admitted for heart failure from 2005 to 2009.
Although the researchers found no difference in mortality between patients treated in the ICU and those treated as regular inpatients, the cost of care in the
ICU for heart failure exacerbation was significantly higher ($ 2,608 more) and heart attack ($ 4,922 more) than regular inpatient care.